Valuation: SIGA Technologies, Inc.

Market Cap 226M 197M 186M 169M 316M 21.65B 317M 2.23B 859M 11.01B 847M 829M 35.41B P/E 2026 *
62.8x
P/E 2027 * 2.91x
Enterprise Value 108M 93.8M 88.57M 80.43M 151M 10.32B 151M 1.06B 409M 5.25B 404M 395M 16.89B EV / Sales 2026 *
1.8x
EV / Sales 2027 * 0.48x
Free-Float
57.27%
Yield 2026 *
19.1%
Yield 2027 * 19.1%
1 day+2.95%
1 week+3.63%
1 month+5.02%
3 months-27.31%
6 months-35.39%
Current year-48.61%
1 week 2.93
Extreme 2.93
3.2
1 month 2.91
Extreme 2.91
3.32
Current year 2.83
Extreme 2.83
7.1
1 year 2.83
Extreme 2.83
9.45
3 years 2.83
Extreme 2.83
12.83
5 years 2.83
Extreme 2.83
26.99
10 years 1.9
Extreme 1.9
26.99
Manager TitleAgeSince
Chief Executive Officer 54 2024-01-26
Director of Finance/CFO 55 2011-02-09
Chief Operating Officer - 2019-12-31
Director TitleAgeSince
Director/Board Member 73 2009-03-10
Director/Board Member 72 2020-06-15
Director/Board Member 42 2020-12-09
Date Insider Type Main position Quantity % Market Cap. Importance
3/25/26 Exercice

General Counsel

17,366 0.0243%
3/13/26 Exercice

General Counsel

121,769 0.1700%
3/13/26 Exercice

Chief Technology Officer

81,787 0.1142%
Change 5-day change 1-year change 3-year change Capi.($)
+2.95%+3.63%-64.60%-30.84% 226M
+0.04%+3.34%+51.12%+101.82% 1,028B
-0.09%+1.66%+55.02%+66.18% 651B
-0.02%+2.66%+18.91%+71.47% 466B
-1.22%+3.66%+36.44%+38.32% 346B
-0.79%+2.73%+19.03%+25.08% 266B
+0.58%+6.76%+11.13%+16.52% 259B
+1.55%+2.20%+39.81%+46.55% 208B
+0.79%+1.84%-28.27%-56.71% 191B
-0.52%+4.45%+32.12%+98.51% 186B
Average +0.48%+3.29%+17.07%+37.69% 360.2B
Weighted average by Cap. +0.23%+3.09%+35.14%+61.76%

Financials

2026 *2027 *
Net sales 59.86M 52.2M 49.29M 44.76M 83.86M 5.74B 84.21M 590M 228M 2.92B 225M 220M 9.4B 162M 141M 133M 121M 227M 15.55B 228M 1.6B 617M 7.91B 609M 595M 25.44B
Net income 3.72M 3.24M 3.06M 2.78M 5.21M 357M 5.23M 36.69M 14.16M 181M 13.97M 13.66M 584M 77.88M 67.92M 64.13M 58.23M 109M 7.47B 110M 768M 296M 3.8B 293M 286M 12.23B
Net Debt -118M -103M -97.19M -88.25M -165M -11.33B -166M -1.16B -449M -5.76B -443M -434M -18.53B -148M -129M -122M -111M -207M -14.19B -208M -1.46B -563M -7.22B -556M -543M -23.22B
Logo SIGA Technologies, Inc.
SIGA Technologies, Inc. is a commercial-stage pharmaceutical company. The Company is focused on the development of medicines to treat and prevent infectious diseases. Its flagship product, TPOXX (tecovirimat), is an antiviral medicine approved in the United States and Canada for the treatment of smallpox and authorized in Europe, the United Kingdom, and Japan for the treatment of smallpox, monkeypox (mpox), cowpox, and vaccinia complications. TPOXX specifically inhibits the activity of a protein called VP37, found on the surface of all orthopoxviruses. This prevents the virus from leaving infected cells, slowing the spread of the infection and limiting it to a point where the immune system can clear the virus. The European Medicines Agency and United Kingdom approvals include labeling for oral tecovirimat indicating its use for the treatment of smallpox, monkeypox, cowpox, and vaccinia complications following vaccination against smallpox.
Employees
49
Date Price Change Volume
26-09-18 US$3.140 +2.95% 746,251
26-09-17 US$3.050 -1.61% 711,059
26-09-16 US$3.100 +4.03% 811,869
26-09-15 US$2.980 -5.40% 480,092
26-09-14 US$3.150 +3.96% 522,908
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
BB

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. SIGA Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!